Skip to main content
Stephan Targan, MD, Infectious Disease, Los Angeles, CA

StephanRTarganMD

Infectious Disease Los Angeles, CA

Distinguished Professor, Department of Medicine, Cedars Sinai Distinguished Professor, UCLA School of Medicine

Dr. Targan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Targan's full profile

Already have an account?

  • Office

    8700 Beverly Blvd
    Los Angeles, CA 90048
    Phone+1 310-423-7723
    Fax+1 310-423-0224

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gastroenterology, 1976 - 1978
  • Los Angeles County-Harbor-UCLA Medical Center
    Los Angeles County-Harbor-UCLA Medical CenterFellowship, Infectious Disease, 1975 - 1976
  • Los Angeles County-Harbor-UCLA Medical Center
    Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 1971 - 1975
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1971

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1972 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Gastroenterology
  • American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2002-2014
  • Top Doctors:LA Area Castle Connolly, 2013
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Insights into the Genetic Epidemiology of Crohn's and Rare Diseases in the Ashkenazi Jewish Population  
    Stephan Targan, Nir Barzilai, Steven R Brant, Manuel A Rivas, PLoS One

Press Mentions

  • Clinical Study Shows Efficacy of Monoclonal Antibody Treatment for Ulcerative Colitis
    Clinical Study Shows Efficacy of Monoclonal Antibody Treatment for Ulcerative ColitisSeptember 26th, 2024
  • NEJM: Results from Targeted Therapy for Ulcerative Colitis Study
    NEJM: Results from Targeted Therapy for Ulcerative Colitis StudySeptember 25th, 2024
  • Cedars-Sinai Expert in Genetics of Inflammatory Bowel Disease Awarded 2024 Sherman Prize for Pioneering Achievements
    Cedars-Sinai Expert in Genetics of Inflammatory Bowel Disease Awarded 2024 Sherman Prize for Pioneering AchievementsSeptember 18th, 2024
  • Join now to see all

Grant Support

  • IBD: Mucosa Specific Regulation Of Ifn-Gamma ProductionNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2012
  • IBD: Genetic And Immunopathologic MechanismsNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
  • The Cedars-Sinai Immunobiology Training ProgramNational Institute Of Allergy And Infectious Diseases2010–2011
  • Role Of TL1A In Severity Of Crohn'S Disease InflammationNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
  • Inflammatory Bowel Disease Center: Clinical Data Repository - Tissue ProcurementNational Center For Research Resources2007–2010
  • Immunopathology &Aggressive Crohn'S Disease ImmunophenotypeNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2009
  • Flagellin Reactivity As A Marker For A Subtype Of Crohn'S DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2009
  • Core--Tissue Procurement &Data Analysis &Serum AnalysisNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2009
  • Core ANational Institute Of Diabetes And Digestive And Kidney Diseases2007–2009
  • IBD: Genetics And Immunopathologic MechanismsNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2009
  • Ibd:Tnf-Alpha And Crohn'S Disease Mucosal InflammationNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2008
  • Immunopathology--Crohn'S Disease ImmunophenotypeNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2006
  • Flagellin Reactivity As A Marker For A Subtype Of CrohnNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2006
  • Core--Tissue Procurement /Data Analysis /Serum AnalysisNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2006
  • Administration CoreNational Institute Of Diabetes And Digestive And Kidney Diseases2005
  • Ibd--Mucosa-Specific Regulation Of Ifn-Gamma ProductionNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2005
  • Ibd--Genetic And Immunopathologic MechanismsNational Institute Of Diabetes And Digestive And Kidney Diseases1995–2004
  • TNF Alpha And Crohns Disease Mucosal InflammationNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2003
  • IBD Disease Subgroup StratificationNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2002
  • Core--Tissue Procurement FacilityNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2002
  • Ibd--Immunogenetic Linkage And Subclinical MarkersNational Center For Research Resources1997–2001
  • Ibd--Role Of Activated T-Cells In Gut InjuryNational Institute Of Diabetes And Digestive And Kidney Diseases1997–2000
  • Trial Of IV Azathiprine Loading In Subjects With Steroid Refactory Crohn'S DISNational Center For Research Resources1997–1999
  • Ulcerative Colitis Specific Panca--Role In Disease PathogenesisNational Institute Of Diabetes And Digestive And Kidney Diseases1996–1999
  • Core--Tissue ProcurementNational Institute Of Diabetes And Digestive And Kidney Diseases1992–1999
  • Ibd--Genetic &Immunopathologic MechanismsNational Institute Of Diabetes And Digestive And Kidney Diseases1994
  • Activated T Cells And Gut InjuryNational Institute Of Diabetes And Digestive And Kidney Diseases1994
  • Ibd--Genetic 7 Immunopathologic MechanismsNational Institute Of Diabetes And Digestive And Kidney Diseases1992–1994
  • IBD: Role Of Antineutrophil Cytoplasmic AntibodiesNational Institute Of Diabetes And Digestive And Kidney Diseases1992–1993
  • Role Of Activated T Cells In Gut InjuryNational Institute Of Diabetes And Digestive And Kidney Diseases1991–1993
  • Ibd--Role Of Antineutrophil Cytoplasmic AntibodiesNational Institute Of Diabetes And Digestive And Kidney Diseases1992
  • Role Of Activated T Cells In Gut InjuryNational Institute Of Diabetes And Digestive And Kidney Diseases1991
  • IBD: Role Of Antineutrophil Cytoplasmic AntibodiesNational Institute Of Diabetes And Digestive And Kidney Diseases1991
  • Mechanism Of The NK Lethal HIT In Programmed Tumor CellsNational Cancer Institute1985–1989
  • Inflammatory Bowel Disease: NK Activity In Gut MucosaNational Institute Of Diabetes And Digestive And Kidney Diseases1986–1987
  • Inflammatory Bowel Disease: NK Activity In Gut MucosaNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985

Professional Memberships